A. Sharma

465 total citations
14 papers, 397 citations indexed

About

A. Sharma is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Sharma has authored 14 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Sharma's work include Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). A. Sharma is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). A. Sharma collaborates with scholars based in United States and Netherlands. A. Sharma's co-authors include William R. Greco, K. R. Weishaupt, Barbara W. Henderson, Ravindra K. Pandey, David A. Bellnier, Lurine A. Vaughan, Thomas J. Dougherty, Ralph J. Bernacki, Charles J. Dimitroff and Fernando Cabral and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Oncology.

In The Last Decade

A. Sharma

13 papers receiving 392 citations

Peers

A. Sharma
Likuan Hu China
Adrianus C. Laan Netherlands
P Hinnen Netherlands
Marc A. Longino United States
Likuan Hu China
A. Sharma
Citations per year, relative to A. Sharma A. Sharma (= 1×) peers Likuan Hu

Countries citing papers authored by A. Sharma

Since Specialization
Citations

This map shows the geographic impact of A. Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sharma more than expected).

Fields of papers citing papers by A. Sharma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sharma. The network helps show where A. Sharma may publish in the future.

Co-authorship network of co-authors of A. Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of A. Sharma. A scholar is included among the top collaborators of A. Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Sharma. A. Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Yin, Da, et al.. (2008). Population pharmacokinetics of CP-751,871, a monoclonal antibody against IGF-I receptor, in patients with multiple myeloma or solid tumors. Journal of Clinical Oncology. 26(15_suppl). 2524–2524. 7 indexed citations
3.
Veltkamp, Stephan A., et al.. (2006). A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application. Cancer Chemotherapy and Pharmacology. 59(1). 43–50. 13 indexed citations
4.
Gómez-Navarro, Jesús, A. Sharma, Viviana Bozón, et al.. (2006). Dose and schedule selection for the anti-CTLA4 monoclonal antibody ticilimumab in patients (pts) with metastatic melanoma. Journal of Clinical Oncology. 24(18_suppl). 8032–8032. 10 indexed citations
5.
Alsina, Melissa, et al.. (2006). Phase 1 first-in-human dose escalation study of cp-751,871, a specific monoclonal antibody against the insulin like growth factor 1 receptor. Journal of Clinical Oncology. 24(18_suppl). 7609–7609. 6 indexed citations
6.
Letrent, Stephen P., D A Noe, A. Qin, et al.. (2006). PI-13Pharmacokinetics and pharmacodynamics of a HER2 tyrosine kinase inhibitor CP-724714 in patients with advanced malignant HER2 positive solid tumors. Clinical Pharmacology & Therapeutics. 79(2). P10–P10. 2 indexed citations
7.
Bulanhagui, C. A., Antoni Ribas, Dmitri Pavlov, et al.. (2006). Phase I clinical trials of ticilimumab: Tumor responses are sufficient but not necessary for prolonged survival. Journal of Clinical Oncology. 24(18_suppl). 8036–8036. 8 indexed citations
8.
Okusanya, Ólanrewaju O., Alan Forrest, Brent M. Booker, et al.. (2005). Pharmacokinetics and pharmacodynamics of azithromycin in gerbils with haemophilus influenzae middle ear infection. Clinical Pharmacology & Therapeutics. 77(2). P89–P89. 1 indexed citations
9.
Foster, Graham R., et al.. (2005). Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy subjects. Clinical Pharmacology & Therapeutics. 77(2). P40–P40. 5 indexed citations
10.
Ojima, Iwao, Jean Veith, Paula Pera, et al.. (2001). Effects of Orally Active Taxanes on P-Glycoprotein Modulation and Colon and Breast Carcinoma Drug Resistance. JNCI Journal of the National Cancer Institute. 93(16). 1234–1245. 74 indexed citations
11.
Dimitroff, Charles J., A. Sharma, & Ralph J. Bernacki. (1998). Cancer Metastasis: A Search for Therapeutic Inhibition. Cancer Investigation. 16(4). 279–290. 27 indexed citations
12.
Rothenberg, Mace L., A. Sharma, Geoffrey R. Weiss, et al.. (1998). Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors. Annals of Oncology. 9(7). 733–738. 67 indexed citations
13.
Henderson, Barbara W., David A. Bellnier, William R. Greco, et al.. (1997). An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy.. PubMed. 57(18). 4000–7. 169 indexed citations
14.
Sharma, A. & Ralph J. Bernacki. (1997). Ovarian cancer patients with high CA-125 but no symptoms--should antiangiogenic treatments be considered?. PubMed. 9(2). 53–4. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026